A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms.

Rabkin, J G; Wagner, G J; Rabkin, R

Rabkin, J G; Wagner, G J; Rabkin, R.

Affiliation

Rabkin JG; New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York 10032, USA. jgr1@Columbia.edu

Arch Gen Psychiatry ; 57(2): 141-7; discussion 155-6, 2000 Feb.

Article in En | MEDLINE | ID: mdl-10665616

Subject(s)

Acquired Immunodeficiency Syndrome/complications; Anabolic Agents/therapeutic use; Hypogonadism/drug therapy; Sexual Dysfunctions, Psychological/drug therapy; Testosterone/analogs & derivatives; Testosterone/deficiency; Acquired Immunodeficiency Syndrome/epidemiology; Comorbidity; Delayed-Action Preparations; Double-Blind Method; Erectile Dysfunction/drug therapy; Erectile Dysfunction/epidemiology; Humans; Hypogonadism/epidemiology; Male; Placebos; Sexual Dysfunctions, Psychological/epidemiology; Testosterone/therapeutic use

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Testosterone / Acquired Immunodeficiency Syndrome / Sexual Dysfunctions, Psychological / Anabolic Agents / Hypogonadism Type of study: Clinical_trials / Diagnostic_studies Limits: Humans / Male Language: En Year: 2000 Type: Article

Search on Google

XML

PubMed Links